| PPD Declares Second Quarter Dividend (Business Wire) WILMINGTON, N.C.----PPD, Inc. today announced that its board of directors declared a cash dividend for the second quarter of 2010 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. us.rd.yahoo.com |
Biogen Idec Inc. Q2 2010 Earnings Call Transcript Biogen Idec Inc. (BIIB)Q2 2010 Earnings CallJuly 20, 2010 8:30 AM ESTComplete Story » seekingalpha.com |
Astra Settles Seroquel Claims AstraZeneca said it has reached a $198 million settlement over claims regarding its antipsychotic drug Seroquel in the U.S. online.wsj.com |
Court Ruling Increases Pressure on Sanofi to Buy Genzyme The Burrill Report submits: By Michael Fitzhugh Sanofi-Aventis (SNY) has lost a legal battle intended to fend off generic competition for Taxotere, a cancer medicine that generated more than 8 percent of its net pharmaceutical sales in 2009. The U.S. District Court ruling invalidates two patents that would have protected Taxotere from generic competition until 2013. Hospira and Apotex, two companies planning to market generic versions of the drug, will be happy to get rolling sooner than that. But for Sanofi, the ruling could have larger implications. Accelerated competition for Taxotere could erode revenue sooner than expected, ratcheting up the pressure to replace it by acquiring Genzyme (GENZ). Genzyme's board rebuffed Sanofi's August offer of $69 per share as too meagerly priced. But already rumors of Sanofi's intentions to raise that bid have surfaced. Sanofi's board could meet within days to approve a higher bid for Genzyme, according to Dow Jones Newswires. A higher bid could prompt Genzyme to allow Sanofi access to confidential financial information on its books and conduct due diligence on the company. Complete Story » seekingalpha.com |
Kensey Nash Corporation CEO Discusses F1Q2011 Results - Earnings Call Transcript Kensey Nash Corporation (KNSY)F1Q2011 (Qtr End 09/30/10) Earnings Conference CallOctober 21, 2010 9 AM ETComplete Story » seekingalpha.com |